What is FDA Phase 2? Understanding Clinical Efficacy and Dosing
•
4 min read
According to the Biotechnology Innovation Organization (BIO), only about 31% of drugs successfully transition from a Phase 2 clinical trial to a Phase 3 study. This high attrition rate underscores the critical importance of successfully navigating **What is FDA Phase 2?**, the pivotal stage focused on confirming a drug's effectiveness and refining its optimal use in patients.
